Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Coku I"'
Publikováno v:
In Heliyon 15 November 2024 10(21)
Autor:
Kumar P; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States., Courtes M; Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France., Lemmers C; Plateforme de Vectorologie de Montpellier (PVM), BioCampus Montpellier, CNRS, INSERM, Université de Montpellier, Montpellier, France., Le Digarcher A; Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France., Coku I; Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France., Monteil A; Plateforme de Vectorologie de Montpellier (PVM), BioCampus Montpellier, CNRS, INSERM, Université de Montpellier, Montpellier, France., Hong C; Vanderbilt University School of Medicine Nashville, Nashville, TN, United States., Varrault A; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States., Liu R; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States., Wang L; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States., Bouschet T; Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France.
Publikováno v:
Frontiers in genetics [Front Genet] 2023 May 05; Vol. 14, pp. 1147222. Date of Electronic Publication: 2023 May 05 (Print Publication: 2023).
Autor:
Coku I; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Mutez E; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; University of Lille, Inserm, CHU Lille, Expert Center for Parkinson's Disease, Lille, France., Eddarkaoui S; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Carrier S; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Marchand A; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Deldycke C; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Goveas L; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Baille G; University of Lille, Inserm, CHU Lille, Expert Center for Parkinson's Disease, Lille, France., Tir M; Department of Neurology and Expert Center for Parkinson's Disease, Amiens University Hospital, CHU Amiens-Picardie, Amiens, France., Magnez R; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France., Thuru X; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France., Vermeersch G; Department of Neurology, AZ Sint-Lucas, Bruges, Belgium., Vandenberghe W; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.; Laboratory for Parkinson Research, Department of Neurosciences, KU Leuven, Leuven, Belgium., Buée L; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Defebvre L; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; University of Lille, Inserm, CHU Lille, Expert Center for Parkinson's Disease, Lille, France., Sablonnière B; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; University of Lille, Inserm, CHU Lille, Department of Toxicology and Genopathies, UF Neurobiology, Lille, France., Chartier-Harlin MC; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Taymans JM; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France., Huin V; University of Lille, Inserm, CHU Lille, U1172-LilNCog (JPARC)-Lille Neuroscience & Cognition, Lille, France.; University of Lille, Inserm, CHU Lille, Department of Toxicology and Genopathies, UF Neurobiology, Lille, France.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Aug; Vol. 37 (8), pp. 1761-1767. Date of Electronic Publication: 2022 Jun 16.